| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Jemal is Strategic Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Xu is Analyst, Mortality Statistics Branch, Division of Vital Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
This article is available online at http://CAonline.AmCancerSoc.org
Each year, the American Cancer Society (ACS) estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. This report considers incidence data through 2003 and mortality data through 2004. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,444,920 new cancer cases and 559,650 deaths for cancers are projected to occur in the United States in 2007. Notable trends in cancer incidence and mortality rates include stabilization of the age-standardized, delay-adjusted incidence rates for all cancers combined in men from 1995 through 2003; a continuing increase in the incidence rate by 0.3% per year in women; and a 13.6% total decrease in age-standardized cancer death rates among men and women combined between 1991 and 2004. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. While the absolute number of cancer deaths decreased for the second consecutive year in the United States (by more than 3,000 from 2003 to 2004) and much progress has been made in reducing mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  J. Michels, S. L. Ellard, L. Le, C. Kollmannsberger, N. Murray, E. S. Tomlinson Guns, R. Carr, and K. N. Chi A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer Ann. Onc., February 1, 2010; 21(2): 305 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Thomsen, L. Ambroisine, S. Wynn, K. S.E. Cheah, C. S. Foster, G. Fisher, D. M. Berney, H. Moller, V. E. Reuter, P. Scardino, et al. SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation Cancer Res., February 1, 2010; 70(3): 979 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Kierans, M. Elazzazi, L. Braga, P. Leonardou, D. A. Gerber, C. Burke, W. Qureshi, M. Kanematsu, and R. C. Semelka Thermoablative Treatments for Malignant Liver Lesions: 10-Year Experience of MRI Appearances of Treatment Response Am. J. Roentgenol., February 1, 2010; 194(2): 523 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kim, J. S. Lim, J. Y. Choi, J. Park, Y. E. Chung, M.-J. Kim, E. Choi, N. K. Kim, and K. W. Kim Rectal Cancer: Comparison of Accuracy of Local-Regional Staging with Two- and Three-dimensional Preoperative 3-T MR Imaging Radiology, February 1, 2010; 254(2): 485 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. C. Chow, M. Ban, H. L. Wu, F. Nguyen, M. Huang, H. Chung, H. Dong, and J. M. Carethers TGF-{beta} downregulates PTEN via activation of NF-{kappa}B in pancreatic cancer cells Am J Physiol Gastrointest Liver Physiol, February 1, 2010; 298(2): G275 - G282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Wong, P. B. Mangu, M. A. Choti, T. S. Crocenzi, G. D. Dodd III, G. S. Dorfman, C. Eng, Y. Fong, A. F. Giusti, D. Lu, et al. American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer J. Clin. Oncol., January 20, 2010; 28(3): 493 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Clough-Gorr, A. E. Stuck, S. S. Thwin, and R. A. Silliman Older Breast Cancer Survivors: Geriatric Assessment Domains Are Associated With Poor Tolerance of Treatment Adverse Effects and Predict Mortality Over 7 Years of Follow-Up J. Clin. Oncol., January 20, 2010; 28(3): 380 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kawaguchi, M. Sho, T. Tojo, I. Yamato, T. Nomi, K. Hotta, K. Hamada, Y. Suzaki, S. Sugiura, K. Kushibe, et al. Clinical Significance of Prostate Stem Cell Antigen Expression in Non-small Cell Lung Cancer Jpn. J. Clin. Oncol., January 18, 2010; (2010) hyp181v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stidley, M. A. Picchi, S. Leng, R. Willink, R. E. Crowell, K. G. Flores, H. Kang, T. Byers, F. D. Gilliland, and S. A. Belinsky Multivitamins, Folate, and Green Vegetables Protect against Gene Promoter Methylation in the Aerodigestive Tract of Smokers Cancer Res., January 15, 2010; 70(2): 568 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-E Wang, Z. Hu, E. M. Sturgis, M. R. Spitz, S. S. Strom, C. I. Amos, Z. Guo, Y. Qiao, A. M. Gillenwater, J. N. Myers, et al. Reduced DNA Repair Capacity for Removing Tobacco Carcinogen-Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics Clin. Cancer Res., January 15, 2010; 16(2): 764 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Roe, A. L. Fitzpatrick, C. Xiong, W. Sieh, L. Kuller, J. P. Miller, M. M. Williams, R. Kopan, M. I. Behrens, and J. C. Morris Cancer linked to Alzheimer disease but not vascular dementia Neurology, January 12, 2010; 74(2): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Reed, C. N. Mayhew, A. K. McClendon, and E. S. Knudsen Unique Impact of RB Loss on Hepatic Proliferation: TUMORIGENIC STRESSES UNCOVER DISTINCT PATHWAYS OF CELL CYCLE CONTROL J. Biol. Chem., January 8, 2010; 285(2): 1089 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Strano, L. Ouafi, M. Baud, and M. Alifano Primary Chordoma of the Lung. Ann. Thorac. Surg., January 1, 2010; 89(1): 302 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Korpanty, E. Smyth, L. A Sullivan, R. A Brekken, and D. N Carney Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway Exp Biol Med, January 1, 2010; 235(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Penson, D. S. Dizon, S. A. Cannistra, M. R. Roche, C. N. Krasner, S. T. Berlin, N. S. Horowitz, P. A. DiSilvestro, U. A. Matulonis, H. Lee, et al. Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors J. Clin. Oncol., January 1, 2010; 28(1): 154 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yoshizawa, J. Fukuoka, S. Shimizu, K. Shilo, T. J. Franks, S. M. Hewitt, T. Fujii, C. Cordon-Cardo, J. Jen, and W. D. Travis Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non-Small Cell Lung Cancer Clin. Cancer Res., January 1, 2010; 16(1): 240 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-W. Shin, C. Pancaro, C. F. Wang, and P. Gerner The Effects of Resiniferatoxin in an Experimental Rat Thoracotomy Model Anesth. Analg., January 1, 2010; 110(1): 228 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pijls-Johannesma, J. P.C. Grutters, F. Verhaegen, P. Lambin, and D. De Ruysscher Do We Have Enough Evidence to Implement Particle Therapy as Standard Treatment in Lung Cancer? A Systematic Literature Review Oncologist, January 1, 2010; 15(1): 93 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Quinn, S. T. Vadaparampil, J.-H. Lee, P. B. Jacobsen, G. Bepler, J. Lancaster, D. L. Keefe, and T. L. Albrecht Physician Referral for Fertility Preservation in Oncology Patients: A National Study of Practice Behaviors J. Clin. Oncol., December 10, 2009; 27(35): 5952 - 5957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soeda, Y. Morita-Hoshi, H. Makiyama, C. Morizane, H. Ueno, M. Ikeda, T. Okusaka, S. Yamagata, N. Takahashi, I. Hyodo, et al. Regular Dose of Gemcitabine Induces an Increase in CD14+ Monocytes and CD11c+ Dendritic Cells in Patients with Advanced Pancreatic Cancer Jpn. J. Clin. Oncol., December 1, 2009; 39(12): 797 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Spector and K. L. Blackwell Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer J. Clin. Oncol., December 1, 2009; 27(34): 5838 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Planque, V. Kulasingam, C. R. Smith, K. Reckamp, L. Goodglick, and E. P. Diamandis Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines Mol. Cell. Proteomics, December 1, 2009; 8(12): 2746 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Lyon, D. M. Klinge, K. C. Do, M. J. Grimes, C. L. Thomas, L. A. Damiani, T. H. March, C. A. Stidley, and S. A. Belinsky Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model Carcinogenesis, December 1, 2009; 30(12): 2095 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chanda, T. Isayeva, S. Kumar, J. A. Hensel, A. Sawant, G. Ramaswamy, G. P. Siegal, M. S. Beatty, and S. Ponnazhagan Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis Clin. Cancer Res., December 1, 2009; 15(23): 7175 - 7185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Okamoto, M. Munakata, M. Miyazaki, T. Satoh, T. Takahata, Y. Takamatsu, O. Muto, K. Koike, K. Ishitani, T. Mukaiyama, et al. Disturbance of the Growth Hormone-Insulin-like Growth Factor-1 Axis Associated with Poor Performance Status in Patients with Solid Tumors Jpn. J. Clin. Oncol., November 25, 2009; (2009) hyp155v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Liu, C.-W. Tsai, T.-C. Hsia, R.-F. Wang, C.-J. Liu, L.-W. Hang, S.-Y. Chiang, C.-H. Wang, R.-Y. Tsai, C.-C. Lin, et al. Interaction of Methylenetetrahydrofolate Reductase Genotype and Smoking Habit in Taiwanese Lung Cancer Patients Cancer Genomics Proteomics, November 1, 2009; 6(6): 325 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Jayaprakash, M. Sullivan, M. Merzianu, N. R. Rigual, T. R. Loree, S. R. Popat, K. B. Moysich, S. Ramananda, T. Johnson, J. R. Marshall, et al. Autofluorescence-Guided Surveillance for Oral Cancer Cancer Prevention Research, November 1, 2009; 2(11): 966 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Deegan, D. Murray, P. Doran, P. Ecimovic, D. C. Moriarty, and D. J. Buggy Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro Br. J. Anaesth., November 1, 2009; 103(5): 685 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Johnson CT Colonography: Coming of Age Am. J. Roentgenol., November 1, 2009; 193(5): 1239 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ito, K. W. Yip, D. Katz, S. B. Fonseca, D. W. Hedley, S. Chow, G. W. Xu, T. E. Wood, C. Bastianutto, A. D. Schimmer, et al. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer Mol. Pharmacol., November 1, 2009; 76(5): 969 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Moretti, D. S. Yu, H. Chen, D. P. Carbone, D. H. Johnson, V. L. Keedy, J. B. Putnam Jr., A. B. Sandler, Y. Shyr, and B. Lu Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy Oncologist, November 1, 2009; 14(11): 1106 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Treat, R. Gonin, M. A. Socinski, M. J. Edelman, R. B. Catalano, D. M. Marinucci, R. Ansari, H. H. Gillenwater, K. M. Rowland, R. L. Comis, et al. A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer Ann. Onc., October 15, 2009; (2009) mdp352v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Holt, M. Shipp, M. Eloubeidi, K. S. Clay, M. A. Smith-Janas, M. J. Janas, K. Britt, M. Norena, and M. N. Fouad Use of focus group data to develop recommendations for demographically segmented colorectal cancer educational strategies Health Educ. Res., October 1, 2009; 24(5): 876 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Troyer, M. S. Lucia, A. P. de Bruine, R. Mendez-Meza, M. M. Baldewijns, N. Dunscomb, M. Van Engeland, T. McAskill, K. Bierau, J. Louwagie, et al. Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2717 - 2722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mancini, E. Vergara, G. Salvatore, A. Greco, G. Troncone, A. Affuso, R. Liuzzi, P. Salerno, M. Scotto di Santolo, M. Santoro, et al. Morphological Ultrasound Microimaging of Thyroid in Living Mice Endocrinology, October 1, 2009; 150(10): 4810 - 4815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Peng, Y.-L. Ran, H. Hu, L. Yu, Q. Liu, Z. Zhou, Y.-M. Sun, L.-C. Sun, J. Pan, L.-X. Sun, et al. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway Carcinogenesis, October 1, 2009; 30(10): 1660 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsujikawa, Y. Yoshida, T. Kudo, Y. Kiyono, T. Kurokawa, M. Kobayashi, T. Tsuchida, Y. Fujibayashi, F. Kotsuji, and H. Okazawa Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with 18F-FDG PET J. Nucl. Med., October 1, 2009; 50(10): 1598 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Syed, S. B. Cheepala, J. N. Gill, J. Stein, C. A. Nathan, J. DiGiovanni, V. Batra, P. Adegboyega, H. E. Kleiner, and J. L. Clifford All-Trans Retinoic Acid Suppresses Stat3 Signaling during Skin Carcinogenesis Cancer Prevention Research, October 1, 2009; 2(10): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oh, B. J. Stish, D. Sachdev, H. Chen, A. Z. Dudek, and D. A. Vallera A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma Clin. Cancer Res., October 1, 2009; 15(19): 6137 - 6147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ishiguro, K. Akimoto, Y. Nagashima, Y. Kojima, T. Sasaki, Y. Ishiguro-Imagawa, N. Nakaigawa, S. Ohno, Y. Kubota, and H. Uemura aPKC{lambda}/{iota} promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6 PNAS, September 22, 2009; 106(38): 16369 - 16374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bellmunt, C. Theodore, T. Demkov, B. Komyakov, L. Sengelov, G. Daugaard, A. Caty, J. Carles, A. Jagiello-Gruszfeld, O. Karyakin, et al. Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract J. Clin. Oncol., September 20, 2009; 27(27): 4454 - 4461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Lu-Yao, P. C. Albertsen, D. F. Moore, W. Shih, Y. Lin, R. S. DiPaola, M. J. Barry, A. Zietman, M. O'Leary, E. Walker-Corkery, et al. Outcomes of Localized Prostate Cancer Following Conservative Management JAMA, September 16, 2009; 302(11): 1202 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Y. Kim, Q. Jin, S.-H. Oh, E. S. Kim, Y. J. Yang, D. H. Lee, L. Feng, C. Behrens, L. Prudkin, Y. E. Miller, et al. Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development Cancer Res., September 15, 2009; 69(18): 7439 - 7448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Lee, B. Y. Choi, J. K. Kundu, Y. K. Shin, H.-K. Na, and Y.-J. Surh Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target Cancer Res., September 15, 2009; 69(18): 7449 - 7458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Krishnaswamy, R. Kanteti, J. S. Duke-Cohan, S. Loganathan, W. Liu, P. C. Ma, M. Sattler, P. A. Singleton, N. Ramnath, F. Innocenti, et al. Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer Clin. Cancer Res., September 15, 2009; 15(18): 5714 - 5723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Epis, K. M. Giles, A. Barker, T. S. Kendrick, and P. J. Leedman miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer J. Biol. Chem., September 11, 2009; 284(37): 24696 - 24704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Ahmed, C. D. Jeffries, P. W. Vos, G. Flake, G. J. Nuovo, D. R. Sinar, W. Naziri, and S. P. Marcuard Diagnostic MicroRNA Markers for Screening Sporadic Human Colon Cancer and Active Ulcerative Colitis in Stool and Tissue Cancer Genomics Proteomics, September 1, 2009; 6(5): 281 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Blackmon, N. Shah, J. A. Roth, A. M. Correa, A. A. Vaporciyan, D. C. Rice, W. Hofstetter, G. L. Walsh, R. Benjamin, R. Pollock, et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann. Thorac. Surg., September 1, 2009; 88(3): 877 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Jonasch, C. G. Wood, S. F. Matin, S.-M. Tu, L. C. Pagliaro, P. G. Corn, A. Aparicio, P. Tamboli, R. E. Millikan, X. Wang, et al. Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma J. Clin. Oncol., September 1, 2009; 27(25): 4076 - 4081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hall, E. Liberman, O. Dulkart, L. Galazan, E. Sagiv, E. Shmueli, D. Kazanov, A. Hallak, M. Moshkowitz, A. Figer, et al. Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant Ann. Onc., September 1, 2009; 20(9): 1517 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O. Witteveen, J. van der Velden, I. Vergote, C. Guerra, C. Scarabeli, C. Coens, G. Demonty, and N. Reed Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group) Ann. Onc., September 1, 2009; 20(9): 1511 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. BROZEK, S. KRIWANEK, E. BONNER, M. PETERLIK, and H. S. CROSS Mutual Associations between Malignancy, Age, Gender, and Subsite Incidence of Colorectal Cancer Anticancer Res, September 1, 2009; 29(9): 3721 - 3726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Moss, M. V. Barbolina, Y. Liu, L. Sun, H. G. Munshi, and M. S. Stack Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination Cancer Res., September 1, 2009; 69(17): 7121 - 7129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oo Khor, S. Yu, A. Barve, X. Hao, J.-L. Hong, W. Lin, B. Foster, M.-T. Huang, H. L. Newmark, and A.-N. Kong Dietary Feeding of Dibenzoylmethane Inhibits Prostate Cancer in Transgenic Adenocarcinoma of the Mouse Prostate Model Cancer Res., September 1, 2009; 69(17): 7096 - 7102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Romero, I. O. Gordon, S. Jagadeeswaran, K. L. Mui, W. S. Lee, D. M. Dinulescu, T. N. Krausz, H. H. Kim, M. L. Gilliam, and E. Lengyel Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice Cancer Prevention Research, September 1, 2009; 2(9): 792 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-R. Yang, Y. Xu, B. Yu, J. Zhou, J.-C. Li, S.-J. Qiu, Y.-H. Shi, X.-Y. Wang, Z. Dai, G.-M. Shi, et al. CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery Clin. Cancer Res., September 1, 2009; 15(17): 5518 - 5527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Komar, S. Kauhanen, K. Liukko, M. Seppanen, S. Kajander, J. Ovaska, P. Nuutila, and H. Minn Decreased Blood Flow with Increased Metabolic Activity: A Novel Sign of Pancreatic Tumor Aggressiveness Clin. Cancer Res., September 1, 2009; 15(17): 5511 - 5517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Ruddy, S. Gelber, J. Shin, J. E. Garber, R. Rosenberg, M. Przypysny, and A. H. Partridge Genetic testing in young women with breast cancer: results from a Web-based survey Ann. Onc., August 27, 2009; (2009) mdp355v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Takano, N. Ishikawa, R. Nishino, K. Masuda, W. Yasui, K. Inai, H. Nishimura, H. Ito, H. Nakayama, Y. Miyagi, et al. Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer Cancer Res., August 15, 2009; 69(16): 6694 - 6703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, Y. Huang, K. Newman, J. Gu, X. Zhang, H. Wu, M. Zhao, Z. Xianyu, and X. Liu Reexpression of Human Somatostatin Receptor Gene 2 Gene Mediated by Oncolytic Adenovirus Increases Antitumor Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand against Pancreatic Cancer Clin. Cancer Res., August 15, 2009; 15(16): 5154 - 5160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Choi, W. E. Barlow, K. S. Albain, C.-C. Hong, J. G. Blanco, R. B. Livingston, W. Davis, J. M. Rae, I-T. Yeh, L. F. Hutchins, et al. Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial Clin. Cancer Res., August 15, 2009; 15(16): 5258 - 5266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Maxwell, Z. Li, D. Jaya, S. Ballard, J. Ferrell, and H. Fu 14-3-3{zeta} Mediates Resistance of Diffuse Large B Cell Lymphoma to an Anthracycline-based Chemotherapeutic Regimen J. Biol. Chem., August 14, 2009; 284(33): 22379 - 22389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kolwijck, P. L.M. Zusterzeel, H. M.J. Roelofs, J. C. Hendriks, W. H.M. Peters, and L. F.A.G. Massuger GSTP1-1 in Ovarian Cyst Fluid and Disease Outcome of Patients With Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2176 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Sullivan and E. D. Crawford Targeted focal therapy for prostate cancer: a review of the literature Therapeutic Advances in Urology, August 1, 2009; 1(3): 149 - 159. [Abstract] [PDF]
|
|
|
|
|
|
M. Li, H. Edamatsu, R. Kitazawa, S. Kitazawa, and T. Kataoka Phospholipase C{varepsilon} promotes intestinal tumorigenesis of ApcMin/+ mice through augmentation of inflammation and angiogenesis Carcinogenesis, August 1, 2009; 30(8): 1424 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zabaleta, L. J. Su, H.-Y. Lin, R. A. Sierra, M. C. Hall, A. O. Sartor, P. E. Clark, J. J. Hu, and A. C. Ochoa Cytokine genetic polymorphisms and prostate cancer aggressiveness Carcinogenesis, August 1, 2009; 30(8): 1358 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. CHIRUMBOLE, N. GUSANI, A. HOWARD, T. LEONARD, P. LEWIS, and J. MUSCAT A Comparison of Stage of Presentation for Pancreatic and Colorectal Cancer in Pennsylvania 2000-2005 Anticancer Res, August 1, 2009; 29(8): 3427 - 3431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hosseini, P. A. Naghan, S. Karimi, S. SeyedAlinaghi, M. Bahadori, K. Khodadad, F. Mohammadi, K. Keynama, and M. R. Masjedi Environmental risk factors for lung cancer in Iran: a case-control study Int. J. Epidemiol., August 1, 2009; 38(4): 989 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yang, A. Boire, A. Agarwal, N. Nguyen, K. O'Callaghan, P. Tu, A. Kuliopulos, and L. Covic Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis Cancer Res., August 1, 2009; 69(15): 6223 - 6231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Ghavami, M Hashemi, S R Ande, B Yeganeh, W Xiao, M Eshraghi, C J Bus, K Kadkhoda, E Wiechec, A J Halayko, et al. Apoptosis and cancer: mutations within caspase genes J. Med. Genet., August 1, 2009; 46(8): 497 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, Y. Zang, M. Sen, R. J. Leeman-Neill, D. SK. Man, J. R. Grandis, and D. E. Johnson Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death Mol. Cancer Ther., August 1, 2009; 8(8): 2211 - 2220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Knudsen and H. I. Scher Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer Clin. Cancer Res., August 1, 2009; 15(15): 4792 - 4798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xie, D. W. Wolff, T. Wei, B. Wang, C. Deng, J. K. Kirui, H. Jiang, J. Qin, P. W. Abel, and Y. Tu Breast Cancer Migration and Invasion Depend on Proteasome Degradation of Regulator of G-Protein Signaling 4 Cancer Res., July 15, 2009; 69(14): 5743 - 5751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bao, M. A. Gorin, M. Zhang, A. C. Ventura, W. C. Pomerantz, S. D. Merajver, T. N. Teknos, A. K. Mapp, and Q. Pan Preclinical Development of a Bifunctional Cancer Cell Homing, PKC{varepsilon} Inhibitory Peptide for the Treatment of Head and Neck Cancer Cancer Res., July 15, 2009; 69(14): 5829 - 5834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Raponi, L. Dossey, T. Jatkoe, X. Wu, G. Chen, H. Fan, and D. G. Beer MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer Cancer Res., July 15, 2009; 69(14): 5776 - 5783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Escudier, T. Eisen, W. M. Stadler, C. Szczylik, S. Oudard, M. Staehler, S. Negrier, C. Chevreau, A. A. Desai, F. Rolland, et al. Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial J. Clin. Oncol., July 10, 2009; 27(20): 3312 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M.G. Larkin, E. L.S. Kipps, C. J. Powell, and C. Swanton Review: Systemic therapy for advanced renal cell carcinoma Therapeutic Advances in Medical Oncology, July 1, 2009; 1(1): 15 - 27. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Mariani, S. C Dowdy, and K. C Podratz The role of pelvic and para-aortic lymph node dissection in the surgical treatment of endometrial cancer: a view from the USA Obstet Gynaecol (Lond), July 1, 2009; 11(3): 199 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, A. Kamat, J. Gu, M. Chen, C. P. Dinney, M. R. Forman, and X. Wu Dietary Intake of Vegetables and Fruits and the Modification Effects of GSTM1 and NAT2 Genotypes on Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2090 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Barrios, C. Sampaio, J. Vinholes, and R. Caponero What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? Ann. Onc., July 1, 2009; 20(7): 1157 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Cohen, C. J. A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. A. Morse, E. Mitchell, M. C. Miller, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer Ann. Onc., July 1, 2009; 20(7): 1223 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Mason, E. V. Morlock, M. R. Karagas, K. T. Kelsey, C. J. Marsit, A. R. Schned, and A. S. Andrew EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis Carcinogenesis, July 1, 2009; 30(7): 1155 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boyle and O. W. Brawley Prostate Cancer: Current Evidence Weighs Against Population Screening CA Cancer J Clin, July 1, 2009; 59(4): 220 - 224. [Full Text] [PDF]
|
|
|
|
|
|
N. Bandi, S. Zbinden, M. Gugger, M. Arnold, V. Kocher, L. Hasan, A. Kappeler, T. Brunner, and E. Vassella miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer Cancer Res., July 1, 2009; 69(13): 5553 - 5559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Kim and S. V. Singh D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells Mol. Cancer Ther., July 1, 2009; 8(7): 1946 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. McElroy, S. Kaushal, H. S. Tran Cao, A.R. Moossa, M. A. Talamini, R. M. Hoffman, and M. Bouvet Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis Mol. Cancer Ther., July 1, 2009; 8(7): 1779 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Russo, K. Jedlicka, M. Wernick, D. McNally, M. Kirk, M. Sproull, S. Smith, U. Shankavaram, A. Kaushal, W. D. Figg, et al. Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer Clin. Cancer Res., July 1, 2009; 15(13): 4292 - 4298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Vahdat, B. Pruitt, C. J. Fabian, R. R. Rivera, D. A. Smith, E. Tan-Chiu, J. Wright, A. R. Tan, N. A. DaCosta, E. Chuang, et al. Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane J. Clin. Oncol., June 20, 2009; 27(18): 2954 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Ferris, E. Bruera, N. Cherny, C. Cummings, D. Currow, D. Dudgeon, N. JanJan, F. Strasser, C. F. von Gunten, and J. H. Von Roenn Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps--From the American Society of Clinical Oncology J. Clin. Oncol., June 20, 2009; 27(18): 3052 - 3058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, H. Huang, L. Sun, M. Yang, C. Pan, W. Chen, D. Wu, Z. Lin, C. Zeng, Y. Yao, et al. MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor Clin. Cancer Res., June 15, 2009; 15(12): 3998 - 4008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yee, M. D. Sadar, D. D. Sin, M. Kuzyk, L. Xing, J. Kondra, A. McWilliams, S.F. P. Man, and S. Lam Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection J. Clin. Oncol., June 10, 2009; 27(17): 2787 - 2792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomida, T. Takeuchi, Y. Shimada, C. Arima, K. Matsuo, T. Mitsudomi, Y. Yatabe, and T. Takahashi Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis J. Clin. Oncol., June 10, 2009; 27(17): 2793 - 2799. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
